-
Safer Use of Medicines
-
Safer use of medicines: the basicsWhy pharmacovigilance?
It's all about patients
What happens to reports?
Spontaneous reporting
Common concepts and terms
-
Take&Tell -
Being part of the bigger pictureMaking sense of the data
-
Annie & Mac's Adventures -
Drugs and Bugs -
Uppsala ReportsUppsala Reports Archive
-
-
Global Pharmacovigilance
-
Global PharmacovigilanceHalf a century of pharmacovigilance
Glossary
-
WHO ProgrammeBeing a member
Join the WHO Programme
Resources and support
The story of UMC and the WHO Programme
-
Specialist centresWHO Collaborating Centres
-
Communication in PharmacovigilancePatient Centered Communications
-
MembersCountry Guidelines
WHO Programme Members
-
VigiFlowAbout VigiFlow
VigiFlow Starter Package
Training videos
Webinars
Documentation
-
PublicationsUMC Publications
WHO Publications
Other Books of Interest
-
- Research & Scientific Development
- Education & Training
-
WHODrug
-
WHODrug PortfolioWHODrug Global
WHODrug Standardised Drug Groupings (SDGs)
WHODrug Koda
WHODrug Cross Reference ATC 5
WHODrug CRT Japan
WHODrug Vendor Programme
-
SubscriptionSubscription fees criteria
WHODrug Subscription Inquiry
Subscription Types
How to subscribe
License Validation Service
-
TrainingOnline WHODrug Training
Webinars
Videocasts
Custom training
-
Access toolsDownload Area
WHODrug CAT
WHODrug Change Request
WHODrug Insight
WHODrug User Area
-
User Group Meetings -
B3/C3 formats upversioningImplementation timeline
Upversioning support
B3/C3 Documents
-
Documents and NewsWhat's New 2019
WHODrug Newsletter 2019
News Archive
-
- VigiBase
- About Us
- UMC Blog
